News
277 - 280 of 348 news items
Plans to revolutionise cardiovascular and respiratory services for patients are intended through a partnership between Royal Brompton & Harefield NHS Foundation Trust and King’s Health Partners
The results of two global clinical research trials in cystic fibrosis (CF) medicine – led by researchers at Royal Brompton Hospital – were presented at the North American CF conference in Indianapolis last week.
Royal Brompton & Harefield NHS Foundation Trust’s partnership with Imperial College London, Imperial College Healthcare NHS Trust and the Royal Marsden NHS Foundation Trust, in the form of the Imperial College Academic Health Science Centre (IC AHSC), has been competitively awarded £1.3 million to develop a National Institute for Health Research London In-Vitro Diagnostics Co-operative (NIHR London IVD Co-operative).
Two experts at Royal Brompton & Harefield NHS Foundation Trust have been called on to help shape the way different respiratory conditions are diagnosed and treated, at home and abroad.